JNJ Quantitative Stock Analysis

Validea's guru fundamental report indicates that Johnson & Johnson (JNJ) scores an 87% using their Multi-Factor Investor model based on Pim van Vliet's strategy, which favors low volatility stocks with strong momentum and high net payout yields. JNJ passes the market cap and standard deviation tests, but is neutral on twelve minus one momentum and net payout yield, ultimately failing the final rank within this specific strategy. The Pim van Vliet strategy focuses on the anomaly that low volatility stocks tend to outperform higher volatility stocks with less risk.

Analysis

Johnson & Johnson (JNJ) has received an 87% rating from Validea's Multi-Factor Investor model, which emulates Pim van Vliet's strategy focused on low volatility stocks exhibiting strong momentum and high net payout yields. This score suggests the strategy has some interest in JNJ, a large-cap growth stock within the Biotechnology & Drugs industry. According to the model's criteria, JNJ passes on market capitalization and standard deviation, indicating favorable low-volatility characteristics. However, the stock receives a neutral rating for both 'twelve minus one momentum' and 'net payout yield'. Despite the 87% score, which generally signifies some alignment, JNJ ultimately records a 'FAIL' on the strategy's final rank. The underlying Pim van Vliet strategy is built on the premise that low volatility stocks can deliver superior returns with less risk compared to their higher volatility counterparts. The specific sentiment for JNJ is moderately positive (0.7), although the broader market impact score associated with this news is low (0.2).

Key Decisions for Investors

• Investors should scrutinize why JNJ received a 'FAIL' on the final rank despite a relatively high initial model score of 87%, particularly focusing on the neutral ratings for momentum and net payout yield.
• Consider that while JNJ exhibits desirable low volatility traits by passing market cap and standard deviation tests, its failure to meet all criteria of this specific multi-factor model suggests it may not be an optimal fit for portfolios strictly adhering to the Pim van Vliet strategy.
• Further investigation into JNJ's momentum and net payout yield metrics is warranted to understand the divergence from the model's ideal profile before making investment decisions based on this specific quantitative screen.